Arlington Trust CO LLC Bristol Myers Squibb CO Transaction History
Arlington Trust CO LLC
- $422 Million
- Q2 2024
A detailed history of Arlington Trust CO LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arlington Trust CO LLC holds 1,856 shares of BMY stock, worth $99,184. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,856
Previous 956
94.14%
Holding current value
$99,184
Previous $51,000
50.98%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,405Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.97 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.48 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.89 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.99 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.16 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $114B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...